FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up
The sBLA for dupilumab (Dupixent) was supported by data from the phase 3 LIBERTY-CUPID clinical program in patients with uncontrolled CSU.
Food Insecurity and the Dangers of Infant Formula Dilution
ACIP votes in favor of recently FDA approved vaccines for meningococcal disease, chikungunya
Recommendations from the ACIP are forwarded to the director of the CDC, and if adopted, become official CDC policy.
Demystifying Infant Formula
Diagnose this 2-month-old with scalp swelling
Can you diagnose this patient? Take our poll and find out! Then check back for the full case, differential diagnosis, and correct diagnosis.
FDA expands diazepam nasal spray for seizure clusters to ages 2–5
Diazepam nasal spray (Valtoco) is approved for short-term treatment of seizure clusters, now in patients aged 2 years and older.
